De novo DNA methyltransferases DNMT3A and DNMT3B are essential for XIST silencing for erosion of dosage compensation in pluripotent stem cells
Atsushi Fukuda(Broad Institute), Kevin Eggan(Broad Institute), Patrizia Mazzucato(Center for Environmental Health), Amanda Beccard(Broad Institute), Francesco Limone(New York University), Jin Hao(Zhejiang University Medical College Affiliated Stomatological Hospital), Dane Z. Hazelbaker(Broad Institute), Lindy E. Barrett(Broad Institute), Angelica Messana(Broad Institute), Chisa Okada(National Defense Medical College), Irune Guerra San Juan(Harvard University), Hidenori Akutsu(National Center For Child Health and Development), Nami Motosugi(Tokai University), Menglu Qian(Broad Institute), Akihiro Umezawa(National Center For Child Health and Development)
Cited by 29
Related Papers
Decreased extra-renal urate excretion is a common cause of hyperuricemia
|Nature Communications|2012|703
ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair
|Nature Neuroscience|2019|697
Cloned mice have an obese phenotype not transmitted to their offspring
|Nature Medicine|2002|358
Progress toward the clinical application of patient-specific pluripotent stem cells
|Journal of Clinical Investigation|2010|332
Assessing the Safety of Human Pluripotent Stem Cells and Their Derivatives for Clinical Applications
|Stem Cell Reports|2017|137